Please assess the completion status of the following clinical trial:

Trial Title: A Randomised Multi-centre Study to Compare the Short-term Outcomes of Minimally Invasive and Conventional Surgery in Primary Total Hip Replacement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~i) Male or female subjects, aged between 18 and 75 years inclusive.~ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.~iii) Subjects who in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.~iv) Subjects with a primary diagnosis of osteoarthritis.~v) Subjects considered suitable for a primary total hip arthroplasty and are considered suitable for a minimally invasive surgical procedure.~Exclusion Criteria:~i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study, or extend their time to discharge beyond that required for their hip replacement surgery.~ii) Women who are pregnant.~iii) Subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes.~iv) Subjects who have participated in a clinical study with an investigational product in the last 6 month(s).~v) Subjects who are currently involved in any injury litigation claims.~vi) Subjects with a Body Mass Index (BMI) \> 30.~vii) Subjects with a malunion, arthrodesis or severe dysplasia with superior femoral head migration.~viii) Subjects requiring a simultaneous bilateral total hip arthroplasty.~ix) Subjects undergoing the second stage of a staged bilateral who are less than 9 months post-arthroplasty

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): DePuy MI System
- 2 (Type: ACTIVE_COMPARATOR): Conventional surgical technique

Based on this trial design, predict the completion outcome and termination type (if applicable).